FDA seeks comments on ibogaine research safeguards through November 20 — sources for revision 1
U.S. Food and Drug Administration
Source date: 2026-10-05.
Supporting location: Research safeguards and comment submission paragraphs.
Federal Register, U.S. Government Publishing Office
Source date: 2026-10-06.
Supporting location: DATES; ADDRESSES; Electronic Submissions; Confidential Submissions; section II preliminary trial-design considerations.
Source dates are distinct from Iliyn’s preparation date. Source statements do not independently prove underlying events. No full source articles or source photographs are reproduced.